New turkish questionnaire could help belgian GPs spot hidden depression

NCT ID NCT07653022

ENROLLING_BY_INVITATION Diagnosis Sponsor: Universitair Ziekenhuis Brussel Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a Turkish translation of the Four-Dimensional Symptom Questionnaire (4DSQ) helps Belgian general practitioners who don't speak Turkish better diagnose depression and anxiety in Turkish-speaking patients with language barriers. About 80 patients and their doctors will take part in interviews to see if the questionnaire improves diagnostic accuracy and treatment decisions. The goal is to provide better mental health support for this community.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Turkish translation of the Four-Dimensional Symptom Questionnaire (4DSQ)
What this could lead to: If successful, this could give doctors a simple tool to better identify depression and anxiety in Turkish-speaking patients who struggle with Dutch or French.
What could go wrong: This is a small, early-stage study with only 80 participants and no control group. The questionnaire may not work as well in real-world clinics or for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION ANXIETY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

mixed anxiety and depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSION ANXIETY DISORDER

Contacts and locations

Locations

Vakgroep Huisartsgeneeskunde en Chronische Zorg

Jette, Brussels Capital, 1090, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.